EA
COV

Euclid Advisors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Euclid Advisors’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-229,720
Closed -$19.9M – 555
2014
Q3 		$19.9M Buy
229,720
+14,820
+7% +$1.31M 0.14% 146
2014
Q2 		$19.4M Sell
214,900
-35,308
-14% -$2.64M 0.14% 165
2014
Q1 		$18.4M Buy
250,208
+65,890
+36% +$4.6M 0.14% 146
2013
Q4 		$12.6M Sell
184,318
-9,480
-5% -$617K 0.1% 197
2013
Q3 		$11.8M Buy
193,798
+16,578
+9% +$1.01M 0.12% 182
2013
Q2 		$9.87M Buy
+177,220
New +$10.2M 0.12% 198

Other funds holding COV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Euclid Advisors's COV Position: Q4 2014 in Review

Euclid Advisors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q4 2014, closing a stake of 229,720 shares — an estimated $19.9M sold.

Euclid Advisors first reported a position in COV in Q2 2013 and held it in 6 quarters. The position peaked at $19.9M in Q3 2014. 758 funds tracked by Wall St. Rank hold COV as of Q4 2014.

  • Euclid Advisors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q4 2014 after selling out during the quarter.
  • Euclid Advisors sold 229,720 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q4 2014, an estimated $19.9M.
  • Euclid Advisors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 6 quarters.
  • Euclid Advisors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $19.9M in Q3 2014.
  • 758 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q4 2014.

Based on Euclid Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.